Fresh analysis indicates that patients who discontinue popular slimming jabs like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who end conventional lifestyle regimens.
Research printed in a major medical journal demonstrates that while obese individuals can lose substantial amounts of their body weight while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month once they quit.
"Users purchasing these medications must be aware of the danger of quick rebound weight gain when the treatment concludes," stated expert Dr. Susan Jebb.
Such speed of recovery implies a reversion to starting mass in about one and a half years.
Analyzing Approaches
The study, which looked at dozens of studies involving thousands of patients, compared the results of the injectable medications with older methods.
Researchers emphasize that individuals who lose weight through dieting usually have a slower creep back—approximately 100 grams monthly—after stopping.
Explaining the Quick Rebound
Experts believe the mechanism of the drugs accounts for the accelerated rebound.
The injections imitate a body's own chemical called GLP-1, which moderates appetite.
"Artificially providing the hormone levels far above than normal could lead to the body to produce less of its own natural hormone, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement leads to hunger is no longer kept in check, making overeating much more probable."
A Chronic Condition?
The NHS suggest the jabs for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.
A number of clinicians contend that, given the high risk of weight regain, the treatment is often life-long.
This perspective is supported by pharmaceutical companies, who note that the findings "highlight the long-term character of obesity," comparing it to managing conditions like diabetes.
User Testimonies
Individuals who have discontinued the jabs describe a powerful return of appetite.
"It was like a switch activating and you become ravenous," said an individual.
This challenge is compounded if individuals have not established sustainable lifestyle or habit changes during therapy.
Widespread Interest
Survey data show that a significant number of adults in the UK have tried these injections in the past year, with desire continuing to grow.
- Adoption is more common among women than males.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the drugs through private prescriptions rather than the NHS.
In conclusion, experts stress that while these medications are effective agents for weight loss, they are not a standalone fix and maintained weight loss likely depends on integrated lifestyle changes.
